Aids commentary cryptococcal meningitis in patients with aids

Journal of Infectious Diseases

Volumn 157, Issue 4, 1988, Pages 624-628

  Dismukes, William E ^a,b  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CRYPTOCOCCUS NEOFORMANS; EDITORIAL; ETIOLOGY; FUNGUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; PRIORITY JOURNAL; TOXOPLASMOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CRYPTOCOCCUS NEOFORMANS; HUMAN; MENINGITIS; OPPORTUNISTIC INFECTIONS; SUPPORT, U.S. GOV'T, P.H.S.; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0023884455     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/157.4.624     Document Type: Article

References (14)

1. Gabuzda DH, Hirsch MS. Neurologic manifestations of infection with human immunodeficiency virus. Clinical features and pathogenesis. Ann Intern Med 1987;107:383-91
2. Levy RM, Bredesen DE, Rosenblum ML. Neurological mani festations of the acquired immunodeficiency syndrome (AIDS): Experience at UCSF and review of the literature. J Neurosurg 1985;62:475-95
3. Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med 1986;104:234-40
4. Eng RHK, Bishburg E, Smith SM, Kapila R. Cryptococcal infections in patients with acquired immune deficiency syndrome. Am J Med 1986;81:19-23
5. Kovacs JA, Kovacs AA, Polis M, Wright WC, Gill VJ, Tua-zon CU, Gelmann EP, Lane HC, Longfield R, Overturf G, Macher AM, Fauci AS, Parrillo JE, Bennett JE, Masur Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 1985;103:533-8
6. Post MJD, Sheldon JJ, Hensley GT, Soila K, Tobias JA, Chan JC, Quencer RM, Moskowitz LB, Central nervous system disease in acquired immunodeficiency syndrome: Prospective correlation using CT, MR imaging, and pathologic studies. Radiology 1986;158:141-8
7. Elkin CM, Leon E, Grenell SL, Leeds NE. Intracranial lesions in the acquired immunodeficiency syndrome. Radiological (computed tomographic) features. JAMA 1985;253:393-6
8. Fujita NK, Reynard M, Sapico FL, Guze LB, Edwards JE Jr. Cryptococcal intracerebral mass lesions. The role of computed tomography and nonsurgical management. Ann Intern Med 1981;94:382-8
9. Kozel TR. Non-encapsulated variant of Cryptococcus neofor-mans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide. Infect Immun 1977;16:99-106
10. Dismukes WE, Cloud G, Gallis HA, Kerkering TM, Medoff G, Craven PC, Kaplowitz LG, Fisher JF, Gregg CR, Bowles CA, Shadomy S, Stamm AM, Diasio RB, Kaufman L, Soong S-J, Blackwelder WC, the National Institute of Allergy and Infectious Diseases Mycoses Study Group. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med 1987;317:334-41
11. Stamm AM, Diasio RB, Dismukes WE, Shadomy S, Cloud GA, Bowles CA, Karam GH, Espinel-Ingroff A, additional members of the National Institute of Allergy and Infectious Diseases Mycoses Study Group. Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. Am J Med 1987;83:236-42
12. Graybill JR, Ahrens J. 51211 (itraconazole) therapy of murine cryptococcosis. Sabouraudia 1984;22:445-53
13. Perfect JR, Savani DV, Durack DT. Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and Candida pyelonephritis in rabbits. Antimicrob Agents Chemother 1986;29:579-83
14. Perfect JR, Durack DT. Penetration of imidazoles and tria-zoles into cerebrospinal fluid of rabbits. J Antimicrob Chemother 1985;16:81-6